Lars Anders
Impact in
- Cancer Research top 5%
- Molecular Biology top 5%
- Genomics and Chromatin Dynamics
- Protein Degradation and Inhibitors
- Epigenetics and DNA Methylation
- Chromatin Remodeling and Cancer
Papers in
-
- Advanced Breast Cancer Therapies 5
-
- Genomics and Chromatin Dynamics 4
- Epigenetics and DNA Methylation 3
- Protein Tyrosine Phosphatases 2
- Chromatin Remodeling and Cancer 2
- Protein Degradation and Inhibitors 1
- Co-authors
- Yoojin Choi (1 shared paper)Richard A. Young (4 shared papers)Piotr Siciński (3 shared papers)Yoon Jong Choi (2 shared papers)Per Hydbring (2 shared papers)Mignon L. Loh (1 shared paper)Marc Vidal (1 shared paper)Huili Zhai (1 shared paper)
- Journals
- Cancer Cell (3 papers)Nature (2 papers)Developmental Cell (1 paper)Targeted Oncology (1 paper)Science (1 paper)
- Partner nations
- United StatesUnited KingdomChina
In The Last Decade
Lars Anders
17 papers receiving 2.7k citations
Lars Anders's Hit Papers
Peers
Comparison fields: 5 of 77
- Cancer Research 356
- Molecular Biology 1.4k
- Oncology 346
- Pulmonary and Respiratory Medicine 307
- Neurology 123
Countries citing papers authored by Lars Anders
This map shows the geographic impact of Lars Anders's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Anders with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Anders more than expected).
Fields of papers citing papers by Lars Anders
This network shows the impact of papers produced by Lars Anders. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Anders. The network helps show where Lars Anders may publish in the future.
Co-authors
The 25 scholars most cited alongside Lars Anders, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element Hit paper breakdown → | 2014 | 632 |
| 2 | Response and resistance to BET bromodomain inhibitors in triple-negative breast cancer Hit paper breakdown → | 2016 | 538 |
| 3 | A Systematic Screen for CDK4/6 Substrates Links FOXM1 Phosphorylation to Senescence Suppression in Cancer Cells Hit paper breakdown → | 2011 | 467 |
| 4 | 2015 | 256 | |
| 5 | 2013 | 246 | |
| 6 | 2013 | 155 | |
| 7 | 2006 | 91 | |
| 8 | 2017 | 87 | |
| 9 | 2020 | 85 | |
| 10 | 2014 | 53 | |
| 11 | CDK4 selective inhibition improves preclinical anti-tumor efficacy and safety Hit paper breakdown → | 2025 | 45 |
| 12 | 2018 | 27 | |
| 13 | 2014 | 24 | |
| 14 | 2025 | 4 | |
| 15 | Furin-, ADAM 10-, and gamma-secretase-mediated cleavage of a receptor tyrosine phosphatase and regulation of beta-catenin's transcriptional activity | 2006 | 3 |
| 16 | 2013 | 1 | |
| 17 | 2024 | 1 | |
| 18 | 2025 | 0 |
About Lars Anders
Lars Anders is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Cancer Research and Neurology, having authored 18 papers that have together received 2.7k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (5 papers), Genomics and Chromatin Dynamics (4 papers), Epigenetics and DNA Methylation (3 papers), Cancer-related Molecular Pathways (3 papers), Protein Tyrosine Phosphatases (2 papers), Chromatin Remodeling and Cancer (2 papers), Protease and Inhibitor Mechanisms (1 paper) and Protein Degradation and Inhibitors (1 paper). The work is most often cited by research in Cancer Research (356 citations), Molecular Biology (1.4k citations), Oncology (346 citations), Pulmonary and Respiratory Medicine (307 citations) and Neurology (123 citations). Lars Anders has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include Yoojin Choi, Richard A. Young, Piotr Siciński, Yoon Jong Choi, Per Hydbring, Mignon L. Loh, Marc Vidal, Huili Zhai, Julia Etchin and Adam David Durbin. Their work appears in journals such as Cancer Cell, Nature, Developmental Cell, Targeted Oncology and Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.